American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis.
Adam CukerEric K TsengRobby NieuwlaatPantep AngchaisuksiriClifton BlairKathryn DaneJennifer DavilaMaria T DeSanchoDavid L DiuguidDaniel O GriffinSusan R KahnFrederikus Albertus KlokAlfred Ian LeeIgnacio NeumannAshok PaiMarc RighiniKristen M SanfilippoDeborah M SiegalMike SkaraDeirdra R TerrellKamshad TouriElie A AklReyad Nayif Al JabiriYazan Nayif Al JabiriAngela M BarbaraAntonio BognanniImad Bou AklMary Ellene BoulosRomina Brignardello-PetersenRana CharideMatthew ChanLuis Enrique Colunga LozanoKarin Lee DearnessAndrea J DarziHeba HusseinSamer G KaramPhilipp KolbRazan MansourGian Paolo MorganoRami Z MorsiGiovanna Muti-SchünemannMenatalla K NadimAtefeh NooriBinu A PhilipThomas PiggottYuan QiuYetiani Roldan BenitezFinn SchünemannAdrienne StevensKarla SoloWojtek WierciochReem A MustafaHolger J SchünemannPublished in: Blood advances (2021)
This recommendation was based on very low certainty in the evidence, underscoring the need for high-quality, randomized controlled trials assessing the role of post-discharge thromboprophylaxis. Other key research priorities include better evidence on assessing risk of thrombosis and bleeding outcomes in patients with COVID-19 after hospital discharge.